Reprint

Surgical Treatment of Pancreatic Ductal Adenocarcinoma

Edited by
November 2021
230 pages
  • ISBN978-3-0365-1866-4 (Hardback)
  • ISBN978-3-0365-1865-7 (PDF)

This book is a reprint of the Special Issue Surgical Treatment of Pancreatic Ductal Adenocarcinoma that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

This book contains the art and science in current standards of surgical treatment of pancreatic ductal adenocarcinoma. It explains the clinical role of surgical resection during multimodal treatment in patients with pancreatic ductal adenocarcinoma, novel surgical techniques including extended pancreatectomy and minimally invasive surgery, risk of cancer in IPMN, and the clinical importance of liquid biopsy.

Format
  • Hardback
License
© by the authors
Keywords
unresectable pancreatic ductal adenocarcinoma; conversion surgery; early recurrence; pancreatic neoplasm/analysis; pancreatic neoplasm/surgery; tumor location; survival; clinical staging; branch duct intraductal papillary mucinous neoplasm; risk factor; malignancy; meta-analysis; laparoscopic; pancreaticoduodenectomy; pancreatic cancer; pancreatic cancer; borderline resectable; neoadjuvant treatment; chemoradiotherapy; prognostic nutritional index; unresectable pancreatic ductal adenocarcinoma; conversion surgery; chemoradiotherapy; isolated local recurrence; pancreatectomy; pancreatic cancer; pancreatic remnant; recurrence; redo surgery; pancreatic cancer; pancreatic exocrine insufficiency; adjuvant chemotherapy; biliary drainage; prehabilitation; ERAS; pancreatic cancer; arterial resection; total pancreatectomy; neoadjuvant therapy; pancreatic ductal adenocarcinoma; surgical treatment; technical advances; pancreatic main duct dilatation; intraductal papillary mucinous neoplasm; high grade dysplasia; invasive carcinoma; pancreatic cystic neoplasm; pancreatic cancer; meta-analysis; cell-free DNA; pancreatic ductal adenocarcinoma; survival; meta-analysis; pancreatic cancer; pancreaticoduodenectomy; mesopancreas; superior mesenteric artery; nerve and fibrous tissues; adjuvant chemotherapy; lymph node dissection; R0 resection; n/a